First patient dosed in SCENESSE® DNA Repair Program
September 15, 2020 03:31 ET
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Xeroderma pigmentosum (XP) patient receives SCENESSE® treatment Note to editors: CLINUVEL is releasing in-depth infographics and a video...
CLINUVEL progresses innovative DNA Repair Program
September 10, 2020 03:18 ET
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced the progression of its drug SCENESSE® (afamelanotide 16mg) to treat the disease xeroderma...
DNA-based Data Storage and Computation Provider CATALOG, Founded by MIT Scientists, Raises $10 Million
September 09, 2020 08:00 ET
|
CATALOG DNA
BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- CATALOG, the world's first DNA-based platform for massive digital data storage and computation, today announced it has secured $10 million in Series A...
Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
August 25, 2020 10:24 ET
|
Codex
San Diego, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, today announced critical advancements in its...
HMI discovers bacterial DNA can trigger Tau protein misfolding in Alzheimer’s disease models, potentially bringing new targets for therapeutic intervention
February 12, 2020 11:04 ET
|
Human Microbiology Institute
New York , Feb. 12, 2020 (GLOBE NEWSWIRE) -- Researchers from Human Microbiology Institute (HMI) and Mitchell Center for Alzheimer’s disease at the University of Texas McGovern Medical School in...
Global Agricultural Biotechnology Market was Valued at USD 33.8 billion by 2024, Observing a CAGR of 10.9% during 2019–2024: VynZ Research
December 17, 2019 13:35 ET
|
VynZ Research
NEW YORK, Dec. 17, 2019 (GLOBE NEWSWIRE) -- The global agricultural biotechnology market was valued at USD 33.8 billion in 2018 and is expected to grow at a CAGR of 10.9% during the forecast period....
Admera Health Announces Appointment of Omar Karame as Chief Financial Officer
December 10, 2019 11:45 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company, welcomes Omar Karame as Chief Financial Officer to the company. Mr. Karame brings to Admera...
Poloxamer Market To Reach USD 38,735 million By 2026 | Reports And Data
August 12, 2019 09:41 ET
|
Reports and Data
New York, Aug. 12, 2019 (GLOBE NEWSWIRE) -- In bioprocess applications, poloxamers are used in cell culture media for their cell cushioning effects because their addition leads to less stressful...
DNA Diagnostics Center®, an Established Global Leader in Diagnostic and Genetic Testing, Names Scott Cramer President and Chief Executive Officer
February 05, 2019 08:00 ET
|
DDC DNA
Fairfield, OH, Feb. 05, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of DNA Diagnostics Center® (DDC®) announces that Scott Cramer has joined DDC as president, chief executive officer, and a...
Admera Health Genetic Tests are Now In-Network with CareFirst BlueCross BlueShield, Maryland, Washington D.C, and Northern Virginia
December 11, 2018 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), an advanced molecular diagnostics company, announced today that its genetic testing services are now...